[11beta-hydroxylase deficiency].

Arq Bras Endocrinol Metabol

Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Campinas, SP.

Published: October 2004

Congenital adrenal hyperplasia due to 11beta-hydroxylase enzyme deficiency is a result of the impairment of 11-deoxycortisol to cortisol conversion. In general, it is responsible for less than 5% of the congenital adrenal hyperplasia cases. The clinical expression of androgen excess in females includes several degrees of genital ambiguity, varying from clitoromegaly to complete virilization. Due to the accumulation of mineralocorticoids, approximately 50% of the patients develop blood hypertension. Mutations in the CYP11B1 gene are responsible for the disease. Biochemical and molecular characteristics of the enzyme and their implications in the clinical presentation of 11beta-hydroxylase deficiency are reviewed here.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0004-27302004000500018DOI Listing

Publication Analysis

Top Keywords

congenital adrenal
8
adrenal hyperplasia
8
[11beta-hydroxylase deficiency]
4
deficiency] congenital
4
hyperplasia 11beta-hydroxylase
4
11beta-hydroxylase enzyme
4
enzyme deficiency
4
deficiency result
4
result impairment
4
impairment 11-deoxycortisol
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!